Insider Trading March 4, 2026

Trupanion COO Sells $140k in Stock as Company Posts Mixed Quarter

John R. Gallagher offloads 5,283 shares under a Rule 10b5-1 plan while Trupanion reports a revenue beat but an EPS shortfall

By Hana Yamamoto TRUP
Trupanion COO Sells $140k in Stock as Company Posts Mixed Quarter
TRUP

Trupanion Chief Operating Officer John R. Gallagher sold 5,283 shares on February 27, 2026, for about $140,080 under a pre-arranged Rule 10b5-1 plan. The stock trades near a 52-week low after a six-month decline. The company reported fourth-quarter 2025 results that beat revenue estimates but missed on earnings per share, and InvestingPro analysis flags an unusually low PEG ratio and a forecast of profitability this year.

Key Points

  • COO John R. Gallagher sold 5,283 shares on February 27, 2026, for approximately $140,080 under a Rule 10b5-1 plan.
  • Trupanion's stock trades near a 52-week low at $27.46 after a six-month decline of 38.5%; weighted average sale price was $26.5153.
  • Fourth-quarter 2025 results showed EPS of $0.13 (missing the $0.16 estimate) and revenue of $376.9 million (beating the $375.21 million forecast); InvestingPro analysis highlights a PEG of 0.2 and projects analyst-predicted profitability this year.

Trupanion Inc. (NASDAQ: TRUP) said its Chief Operating Officer, John R. Gallagher, disposed of 5,283 shares of common stock on February 27, 2026, resulting in proceeds of roughly $140,080. The disposal was carried out at a weighted average price of $26.5153 per share, with the individual trade prices ranging between $26.08 and $26.84. The transaction was executed under a pre-established Rule 10b5-1 trading plan that Gallagher adopted on August 20, 2025.

Following the sale, Gallagher retains direct ownership of 32,387 Trupanion shares. At present, Trupanion's shares trade at $27.46, which places the stock close to its 52-week low point of $25.24. The company has endured a difficult six-month stretch in the market, with the share price down 38.5% over that period.


Quarterly results and market context

In other company developments, Trupanion released fourth-quarter financial results for 2025 that showed mixed outcomes. Reported earnings per share were $0.13, undershooting the expected $0.16, a shortfall of 18.75% relative to the projection. On the revenue side, Trupanion posted $376.9 million for the quarter, narrowly exceeding the forecast of $375.21 million and representing a 12% year-over-year increase.

These results indicate that while the company was able to top revenue expectations, reported EPS did not meet consensus. The company has not disclosed any mergers or acquisitions in the recent updates, and there have been no announced analyst upgrades or downgrades at this time.


Valuation note from market analysis

InvestingPro analysis cited in company coverage describes Trupanion as appearing undervalued at current price levels. The analysis notes a PEG ratio of 0.2 and states that analysts expect the company to be profitable this year. The InvestingPro commentary and additional tips were presented as part of the market perspective on TRUP's investment potential.


What the transaction and results together show

The insider sale, executed under a Rule 10b5-1 plan, is a specific, pre-arranged disposition and does not by itself indicate any new corporate developments beyond the reported quarterly results. The contemporaneous financial disclosures show a revenue beat but an EPS miss, while third-party analysis points to low valuation metrics and a forecast of near-term profitability.

Investors looking at Trupanion will see a mix of signals: a sizable multi-month share price decline, a management share sale under a pre-arranged plan, a quarterly revenue increase, and an earnings shortfall. No recent M&A activity or analyst rating changes have been reported in connection with these events.

Risks

  • Share price has fallen 38.5% over six months and is trading close to its 52-week low - this affects investor sentiment in equity markets and the insurance sector.
  • Fourth-quarter EPS missed estimates by 18.75% despite a revenue beat, creating earnings uncertainty for the company and potentially impacting financial market perception.
  • No recent analyst upgrades or downgrades and no reported mergers or acquisitions - limited new external catalysts to alter near-term market view.

More from Insider Trading

Intuitive Surgical EVP Sells $2.36M in Stock Amid Robust Q4 Results Mar 4, 2026 USANA CIO Disposes of 4,553 Shares as Company Updates Revenue Outlook Mar 4, 2026 Meta CFO Susan J. Li Disposes $36.4 Million in Class A Shares Mar 4, 2026 AppTech Payments Director Adds $31,350 in Stock Across Two Trades; Debt Terms Amended Mar 4, 2026 Synchrony Financial EVP Disposes $878,875 in Stock While Receiving Vesting RSUs Mar 4, 2026